These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22162467)

  • 1. Muscle-bone characteristics in children with Prader-Willi syndrome.
    Edouard T; Deal C; Van Vliet G; Gaulin N; Moreau A; Rauch F; Alos N
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E275-81. PubMed ID: 22162467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on body composition and bone density in children with Prader-Willi syndrome.
    Rubin DA; Cano-Sokoloff N; Castner DL; Judelson DA; Wright P; Duran A; Haqq AM
    Horm Res Paediatr; 2013; 79(5):271-6. PubMed ID: 23615452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthropometric adjustments are helpful in the interpretation of BMD and BMC Z-scores of pediatric patients with Prader-Willi syndrome.
    Hangartner TN; Short DF; Eldar-Geva T; Hirsch HJ; Tiomkin M; Zimran A; Gross-Tsur V
    Osteoporos Int; 2016 Dec; 27(12):3457-3464. PubMed ID: 27377921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial.
    de Lind van Wijngaarden RF; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; van Leeuwen M; Haring DA; Bocca G; Mieke Houdijk EC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3763-71. PubMed ID: 19622627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children.
    Ward KA; Roberts SA; Adams JE; Mughal MZ
    Bone; 2005 Jun; 36(6):1012-8. PubMed ID: 15876561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Circulating Mediators of Bone Remodeling in Prader-Willi Syndrome.
    Brunetti G; Grugni G; Piacente L; Delvecchio M; Ventura A; Giordano P; Grano M; D'Amato G; Laforgia D; Crinò A; Faienza MF
    Calcif Tissue Int; 2018 Jun; 102(6):635-643. PubMed ID: 29353451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peculiar body composition in patients with Prader-Labhart-Willi syndrome.
    Brambilla P; Bosio L; Manzoni P; Pietrobelli A; Beccaria L; Chiumello G
    Am J Clin Nutr; 1997 May; 65(5):1369-74. PubMed ID: 9129464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density in young adults with Prader-Willi syndrome: A randomized, placebo-controlled, crossover GH trial.
    Donze SH; Kuppens RJ; Bakker NE; van Alfen-van der Velden JAEM; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):806-812. PubMed ID: 29418016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD.
    Jørgensen AP; Ueland T; Sode-Carlsen R; Schreiner T; Rabben KF; Farholt S; Høybye C; Christiansen JS; Bollerslev J
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E753-60. PubMed ID: 23436915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone treatment and bone mineral density in pediatric patients with Prader-Willi syndrome.
    Oto Y; Murakami N; Inoue T; Matsubara K; Saima S; Ogata H; Ihara H; Nagai T; Matsubara T
    J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1181-1184. PubMed ID: 34162033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adults with Prader-Willi syndrome have weaker bones: effect of treatment with GH and sex steroids.
    Longhi S; Grugni G; Gatti D; Spinozzi E; Sartorio A; Adami S; Fanolla A; Radetti G
    Calcif Tissue Int; 2015 Feb; 96(2):160-6. PubMed ID: 25577526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral adipose tissue increases shortly after the cessation of GH therapy in adults with Prader-Willi syndrome.
    Koizumi M; Ida S; Shoji Y; Nishimoto Y; Etani Y; Kawai M
    Endocr J; 2018 Nov; 65(11):1127-1137. PubMed ID: 30185718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 8 years of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
    Grootjen LN; Rutges JPHJ; Damen L; Donze SH; Juriaans AF; Kerkhof GF; Hokken-Koelega ACS
    Eur J Endocrinol; 2021 May; 185(1):47-55. PubMed ID: 33886496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative Contributions of Lean and Fat Mass to Bone Mineral Density: Insight From Prader-Willi Syndrome.
    Viardot A; Purtell L; Nguyen TV; Campbell LV
    Front Endocrinol (Lausanne); 2018; 9():480. PubMed ID: 30186239
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body composition in Prader-Willi syndrome compared with nonsyndromal obesity: Relationship to physical activity and growth hormone function.
    van Mil EG; Westerterp KR; Gerver WJ; Van Marken Lichtenbelt WD; Kester AD; Saris WH
    J Pediatr; 2001 Nov; 139(5):708-14. PubMed ID: 11713451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.